CXCL12 mediates apoptosis resistance in rat C6 glioma cells

Oncology Reports

Volumn 27, Issue 5, 2012, Pages 1348-1352

  Hattermann, Kirsten ^a   Mentlein, Rolf ^a   Held Feindt, Janka ^b  

^a UNIVERSITY OF KIEL   (Germany)

^b UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

Author keywords

Apoptosis resistance; Brain tumor; Chemokines; Receptors

Indexed keywords

CHEMOKINE RECEPTOR CXCR4; CHEMOKINE RECEPTOR CXCR7; STROMAL CELL DERIVED FACTOR 1; TEMOZOLOMIDE;

ANIMAL CELL; APOPTOSIS; ARTICLE; CANCER GROWTH; CELL PROLIFERATION; CELL PROTECTION; CONTROLLED STUDY; DRUG EFFECT; DRUG RESISTANCE; GENETIC TRANSCRIPTION; GLIOMA; GLIOMA CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT;

ANIMALS; ANTINEOPLASTIC AGENTS, ALKYLATING; APOPTOSIS; CELL PROLIFERATION; CHEMOKINE CXCL12; DACARBAZINE; GLIOMA; RATS; RECEPTORS, CXCR; RECEPTORS, CXCR4; TRANSCRIPTION, GENETIC;

EID: 84858235813     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2012.1674     Document Type: Article

References (34)

1. Stupp R, Mason WP, van den Bent MJ, et al: Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352: 987-996, 2005. (Pubitemid 40349501)
2. Van Damme J, Decock B, Conings R, Lenaerts JP, Opdenakker G and Billiau A: The chemotactic activity for granulocytes produced by virally infected fibroblasts is identical to monocyte-derived interleukin 8. Eur J Immunol 19: 1189-1194, 1989. (Pubitemid 19196894)
3. Rollins BJ: Chemokines. Blood 90: 909-928, 1997.
4. Reiss K, Mentlein R, Sievers J and Hartmann D: Stromal cell-derived factor 1 is secreted by meningeal cells and acts as chemotactic factor on neuronal stem cells of the cerebellar external granular layer. Neuroscience 115: 295-305, 2002. (Pubitemid 35232708)
5. Hattermann K, Ludwig A, Gieselmann V, Held-Feindt J and Mentlein R: The chemokine CXCL16 induces migration and invasion of glial precursor cells via its receptor CXCR6. Mol Cell Neurosci 39: 133-141, 2008.
6. Asensio VC and Campbell IL: Chemokines in the CNS: pluri-functional mediators in diverse states. Trends Neurosci 22: 504-512, 1999. (Pubitemid 29481851)
7. Balkwill F: Cancer and the chemokine network. Nat Rev Cancer 4: 540-550, 2004.
8. Vandercappellen J, Van Damme J and Struyf S: The role of CXC chemokines and their receptors in cancer. Cancer Lett 267: 226-244, 2008.
9. Müller A, Homey B, Soto H, et al: Involvement of chemokine receptors in breast cancer metastasis. Nature 410: 50-56, 2001. (Pubitemid 32225831)
10. Rempel SA, Dudas S, Ge S and Gutierrez JA: Identification and localization of the cytokine SDF1 and its receptor, CXC chemokine receptor 4, to regions of necrosis and angiogenesis in human glioblastoma. Clin Cancer Res 6: 102-111, 2000. (Pubitemid 30064982)
11. Ehtesham M, Mapara KY, Stevenson CB and Thompson RC: CXCR4 mediates the proliferation of glioblastoma progenitor cells. Cancer Lett 274: 305-312, 2009.
12. Balabanian K, Lagane B, Infantino S, et al: The chemokine SDF-1/CXCL12 binds to and signals through the orphan receptor RDC1 in T lymphocytes. J Biol Chem 280: 35760-35766, 2005. (Pubitemid 41532769)
13. Schönemeier B, Kolodziej A, Schulz S, Jacobs S, Hoellt V and Stumm R: Regional and cellular localization of the CXCl12/SDF-1 chemokine receptor CXCR7 in the developing and adult rat brain. J Comp Neurol 510: 207-220, 2008.
14. Ödemis V, Boosmann K, Heinen A, Kury P and Engele J: CXCR7 is an active component of SDF-1 signalling in astrocytes and Schwann cells. J Cell Sci 123: 1081-1088, 2010.
15. Göttle P, Kremer D, Jander S, et al: Activation of CXCR7 receptor promotes oligodendroglial cell maturation. Ann Neurol 68: 915-924, 2010.
16. Hattermann K, Held-Feindt J, Lucius R, et al: The chemokine receptor CXCR7 is highly expressed in human glioma cells and mediates antiapoptotic effects. Cancer Res 70: 3299-3308, 2010.
17. Thelen M and Thelen S: CXCR7, CXCR4 and CXCL12: an eccentric trio? J Neuroimmunol 198: 9-13, 2008.
18. Sanchez-Alcaniz JA, Haege S, Mueller W, et al: Cxcr7 controls neuronal migration by regulating chemokine responsiveness. Neuron 69: 77-90, 2011.
19. Mentlein R and Held-Feindt J: Pleiotrophin, an angiogenic and mitogenic growth factor, is expressed in human gliomas. J Neurochem 83: 747-753, 2002. (Pubitemid 35316024)
20. Held-Feindt J, Hattermann K, Muerkoster SS, et al: CX3CR1 promotes recruitment of human glioma-infiltrating microglia/macrophages (GIMs). Exp Cell Res 316: 1553-1566, 2010.
21. Held-Feindt J, Hattermann K, Knerlich-Lukoschus F, Mehdorn HM and Mentlein R: SP100 reduces malignancy of human glioma cells. Int J Oncol 38: 1023-1030, 2011.
22. Nicoletti I, Migliorati G, Pagliacci MC, Grignani F and Riccardi C: A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. J Immunol Methods 139: 271-279, 1991.
23. Ma YH, Mentlein R, Knerlich F, Kruse ML, Mehdorn HM and Held-Feindt J: Expression of stem cell markers in human astrocytomas of different WHO grades. J Neurooncol 86: 31-45, 2008. (Pubitemid 350263430)
24. Neel NF, Schutyser E, Sai J, Fan GH and Richmond A: Chemokine receptor internalization and intracellular trafficking. Cytokine Growth Factor Rev 16: 637-658, 2005. (Pubitemid 41505521)
25. Luker KE, Steele JM, Mihalko LA, Ray P and Luker GD: Constitutive and chemokine-dependent internalization and recycling of CXCR7 in breast cancer cells to degrade chemokine ligands. Oncogene 29: 4599-4610, 2010.
26. Benda P, Lightbody J, Sato G, Levine L and Sweet W: Differentiated rat glial cell strain in tissue culture. Science 161: 370-371, 1968.
27. Koch M, May U, Kuhns S, et al: Interleukin 27 induces differentiation of neural C6-precursor cells into astrocytes. Biochem Biophys Res Commun 364: 483-487, 2007. (Pubitemid 350026493)
28. Dziembowska M, Tham TN, Lau P, Vitry S, Lazarini F and Dubois-Dalcq M: A role for CXCR4 signaling in survival and migration of neural and oligodendrocyte precursors. Glia 50: 258-269, 2005. (Pubitemid 40769855)
29. Burns JM, Summers BC, Wang Y, et al: A novel chemokine receptor for SDF-1 and I-TAC involved in cell survival, cell adhesion, and tumor development. J Exp Med 203: 2201-2213, 2006. (Pubitemid 44352240)
30. Rajagopal S, Kim J, Ahn S, et al: Beta-arrestin- but not G protein-mediated signaling by the 'decoy' receptor CXCR7. Proc Natl Acad Sci USA 107: 628-632, 2010.
31. Wang Y, Li G, Stanco A, et al: CXCR4 and CXCR7 have distinct functions in regulating interneuron migration. Neuron 69: 61-76, 2011.
32. Miekus K, Jarocha D, Trzyna E and Majka M: Role of I-TAC-binding receptors CXCR3 and CXCR7 in proliferation, activation of intracellular signaling pathways and migration of various tumor cell lines. Folia Histochem Cytobiol 48: 104-111, 2010.
33. Zheng K, Li HY, Su XL, et al: Chemokine receptor CXCR7 regulates the invasion, angiogenesis and tumor growth of human hepatocellular carcinoma cells. J Exp Clin Cancer Res 29: 31, 2010.
34. Miao Z, Luker KE, Summers BC, et al: CXCR7 (RDC1) promotes breast and lung tumor growth in vivo and is expressed on tumor-associated vasculature. Proc Natl Acad Sci USA 104: 15735-15740, 2007. (Pubitemid 350035369)